Fundz

Sycamore Biopharma, Inc. reported raising $500,000 in an initial SEC Form D filing, from an offering of $500,000

PRIVATEDec 20, 2019

Amount Raised

$500,000

$500,000 sold, per SEC Form D (first sale Dec 20, 2019)

Round Type

Seed

Canal Name Not AvailableBiotechnologyHealth CareDietary Supplements

Quick answer

Sycamore Biopharma raised $500,000 in a Seed round, dated December 20, 2019. Sycamore Biopharma is based in Canal Name Not Available, Florida, United States.

How much did Sycamore Biopharma raise?
Sycamore Biopharma raised $500,000 in a Seed round on December 20, 2019.
What does Sycamore Biopharma do?
Sycamore BioPharma, LLC is an established developer of plant-based pharmaceuticals with a reputation for offering a meticulously curated line of wellness solutions.
Where is Sycamore Biopharma based and how big is it?
Sycamore Biopharma is based in Canal Name Not Available, Florida, United States.

Source: Fundz verified event record.

Who else raised in Dietary Supplements and Biotechnology around the same time

Companies in the same sectors as Sycamore Biopharma that raised within 45 days of this round, from Fundz verified event records.

  • Vaccinex raised $7.5M on February 3, 2020.
  • VistaGen raised $2.8M (Seed) on January 31, 2020.
  • Lynx Dx raised $925K (Seed) on January 29, 2020.
  • American Bitcoin raised $16M on January 28, 2020.
  • Immuneering raised $20M on January 27, 2020.
  • Interpace Biosciences raised $47M on January 27, 2020.

Who to call at Sycamore Biopharma, and when

A new round usually means Sycamore Biopharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sycamore Biopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sycamore Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sycamore Biopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sycamore Biopharma

Location

167 Lott Ct.

Canal Name Not Available, Florida, United States

About

Sycamore BioPharma, LLC is an established developer of plant-based pharmaceuticals with a reputation for offering a meticulously curated line of wellness solutions. The company is known for its high-quality ready-to-sell inventory, including wellness solutions such as gummies, compression sleeves, and pain-relieving topical creams. Sycamore BioPharma's expertise lies in botanical extracts, sustainable plant-based products, and natural Active Pharmaceutical Ingredients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sycamore Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Sycamore Biopharma's next move

See what Strategic adds

Sycamore Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.